BioLineRx (BLRX), Genentech Enter Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab
Go back to BioLineRx (BLRX), Genentech Enter Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab| Bioline RX Ltd Ordinary shares (AMEX: BLNEF) | Delayed: 0.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.86 | 52 Week High | $1.54 | |||
| Open | $1.64 | 52 Week Low | $1.15 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $0.00 | |||
| Volume | 1,500 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 0.64 -0.04 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.68 | 52 Week High | $1.63 | |||
| Open | $0.66 | 52 Week Low | $0.71 | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.62 | EPS | $0.00 | |||
| Volume | 423,242 | |||||
